Protocol No.: S2107
- Title
- Randomized Phase II trial of encorafenib and cetuximab with or without nivolumab (NSC #748726) for patients with previously treated, microsatellite stable, BRAFV600E metastatic and/or unresectable colorectal cancer
- Principal Investigator
- Daboul, Nour
- Phase
- II
- Age Group
- Adult
- Applicable Disease Site
- Gastrointestinal Cancers
- Participating Institutions
- Mary Babb Randolph Cancer Center
- United Hospital Center
- Contacts
- Sabrina Rexroad, RN
- Research Nurse
- Phone: +1 304-293-6066
- Email: sabrina.martinvernon@hsc.wvu.edu
- Karla Schartiger
- Coordinator
- Phone: +1 681-342-1842
- Email: karla.schartiger@wvumedicine.org
- Nnennaya Opara
- Clinical Research Specialist
- Phone: +1 681-342-1000
- Email: nnennaya.opara1@wvumedicine.org